ANAVEX LIFE SCIENCES CORP (AVXL) Forecast, Price Target & Analyst Ratings

NASDAQ:AVXLUS0327973006

Current stock price

3.64 USD
+0.24 (+7.06%)
At close:
3.71 USD
+0.07 (+1.92%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ANAVEX LIFE SCIENCES CORP (AVXL).

Forecast Snapshot

Consensus Price Target

Price Target
$22.44
+ 516.48% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 7, 2026
Period
Q2 / 2026
EPS Estimate
-$0.08
Revenue Estimate

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$22.44
Upside
+ 516.48%
From current price of $3.64 to mean target of $22.44, Based on 9 analyst forecasts
Low
$20.20
Median
$22.44
High
$25.20

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for AVXL. The average price target is 22.44 USD. This implies a price increase of 516.48% is expected in the next year compared to the current price of 3.64.

Analyst Ratings & History

Current Analyst Ratings

AVXL Current Analyst RatingAVXL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

AVXL Historical Analyst RatingsAVXL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
AVXL was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about AVXL.
In the previous month the buy percentage consensus was at a similar level.
AVXL was analyzed by 9 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-31D. Boral CapitalMaintains Buy -> Buy
2026-03-26D. Boral CapitalMaintains Buy -> Buy
2026-03-23D. Boral CapitalMaintains Buy -> Buy
2026-02-10HC Wainwright & Co.Reiterate Buy -> Buy
2026-02-09D. Boral CapitalMaintains Buy -> Buy
2026-01-06D. Boral CapitalMaintains Buy -> Buy
2025-12-19D. Boral CapitalMaintains Buy -> Buy
2025-12-15D. Boral CapitalMaintains Buy -> Buy
2025-11-28HC Wainwright & Co.Reiterate Buy -> Buy
2025-11-26D. Boral CapitalMaintains Buy -> Buy
2025-11-19HC Wainwright & Co.Maintains Buy -> Buy
2025-11-14D. Boral CapitalMaintains Buy -> Buy
2025-10-29D. Boral CapitalMaintains Buy -> Buy
2025-10-24Jones TradingDowngrade Buy -> Hold
2025-10-07HC Wainwright & Co.Reiterate Buy -> Buy
2025-10-02D. Boral CapitalMaintains Buy -> Buy
2025-10-01D. Boral CapitalMaintains Buy -> Buy
2025-09-10D. Boral CapitalMaintains Buy -> Buy
2025-09-10HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-27D. Boral CapitalMaintains Buy -> Buy
2025-08-22HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-13D. Boral CapitalMaintains Buy -> Buy
2025-08-04D. Boral CapitalMaintains Buy -> Buy
2025-04-07D. Boral CapitalMaintains Buy -> Buy
2025-04-07HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 7, 2026
Period
Q2 / 2026
EPS Estimate
-$0.08
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
41.15%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
34.78%

Next Earnings Summary

AVXL is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -0.08 USD and the consensus revenue estimate is 0 USD.

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
AVXL revenue by date.AVXL revenue by date.
N/AN/AN/A
105.48%
N/A
375.37%
N/A
24.13%
N/A
62.60%
N/A
31.13%
N/A
36.36%
EBITDA
YoY % growth
AVXL ebitda by date.AVXL ebitda by date.
-7.11M-15.59M
-119.27%
-15.68M
-0.58%
N/AN/AN/AN/AN/AN/A
-23.91%
N/A
-31.58%
N/A
294.67%
N/A
243.84%
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
AVXL ebit by date.AVXL ebit by date.
-7.11M-15.59M
-119.27%
-15.68M
-0.58%
-19.33M
-23.28%
-29.11M
-50.59%
-31.09M
-6.80%
-42M
-35.09%
-50.99M
-21.40%
-55.76M
-9.35%
-52.877M
5.17%
-51.408M
2.78%
N/A
33.30%
N/A
66.20%
N/A
2,552.12%
N/A
122.23%
N/A
25.09%
N/A
65.32%
N/A
32.54%
N/A
36.80%
Operating Margin
AVXL operating margin by date.AVXL operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
AVXL eps by date.AVXL eps by date.
N/A-0.42
-274.33%
N/A
10.14%
N/A-0.54
-43.08%
-0.45
16.67%
-0.53
-17.78%
-0.62
-16.98%
-0.60
3.23%
-0.52
13.33%
-0.54
-3.85%
N/A
38.61%
N/A
56.92%
N/A
1,721.43%
N/A
105.29%
N/A
12.23%
N/A
49.71%
N/A
25.54%
N/A
31.33%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.08
41.15%
-0.08
49.00%
-0.11
2.64%
-0.12
-104.00%
-0.13
-73.33%
-0.14
-75.00%
-0.15
-42.86%
Revenue
Q2Q % growth
N/AN/AN/AN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-8.181M
34.62%
-8.631M
40.31%
-10.558M
2.64%
N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

AVXL Yearly Revenue VS EstimatesAVXL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
AVXL Yearly EPS VS EstimatesAVXL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 4 6 8 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
84.57%
EPS Next 5 Year
64.04%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

ANAVEX LIFE SCIENCES CORP / AVXL Forecast FAQ

What do analysts expect the price target to be for ANAVEX LIFE SCIENCES CORP (AVXL)?

9 analysts have analysed AVXL and the average price target is 22.44 USD. This implies a price increase of 516.48% is expected in the next year compared to the current price of 3.64.

What is the next earnings date for AVXL stock?

ANAVEX LIFE SCIENCES CORP (AVXL) will report earnings on 2026-05-07.

What are the consensus estimates for ANAVEX LIFE SCIENCES CORP (AVXL) next earnings?

The consensus EPS estimate for the next earnings of ANAVEX LIFE SCIENCES CORP (AVXL) is -0.08 USD and the consensus revenue estimate is 0 USD.

What is the consensus rating for ANAVEX LIFE SCIENCES CORP (AVXL) stock?

The consensus rating for ANAVEX LIFE SCIENCES CORP (AVXL) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.